Cholinergic improvement of a naturally-occurring memory deficit in the young rat

Brain Research

Volumn 707, Issue 1, 1996, Pages 13-21

  Smith, Richard D ^a   Kistler, Michael K ^a   Cohen Williams, Mary ^a   Coffin, Vicki L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Arecoline; Atropine; Consolidation; Development; Memory; Passive avoidance response; Pilocarpine; Scopolamine

Indexed keywords

AMPHETAMINE; ARECOLINE; ATROPINE; CHOLINESTERASE INHIBITOR; DIAZEPAM; DONEPEZIL; HALOPERIDOL; IMIPRAMINE; MECAMYLAMINE; MUSCARINIC AGENT; N METHYL DEXTRO ASPARTIC ACID; NICOTINE; OXOTREMORINE; PARGYLINE; PHENOBARBITAL; PILOCARPINE; PIRACETAM; SCOPOLAMINE; TACRINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CHOLINERGIC SYSTEM; CONTROLLED STUDY; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030024742     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01207-9     Document Type: Article

References (58)

1. Aigner, T.G. and Mishkin, M., The effects of physostigmine and scopolamine on recognition memory in monkeys, Behav. Neur. Biol., 45 (1986) 81-87.
2. Bierer, L.M., Haroutunian, V., Gabriel, S., Knott, P.J., Carlin, L.S., Purohit, D.P., Perl, D.P., Schmeidler, J., Kanof, P. and Davis, K.L., Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits, J. Neurochem., 64 (1995) 749-760.
3. Blozovski, D. and Hennocq, N., Effects of antimuscarinic cholinergic drugs injected systemically or into the hippocampal-entorhinal area upon passive avoidance learning in young rats, Psychopharmacology, 76 (1982) 351-358.
4. Blozovski, D. and Buser, P., Passive avoidance memory consolidation and reinstatement in the young rat, Neurosci. Lett., 89 (1988) 114-119.
5. Blozovski, D., Cudennec, A. and Garrigou, D., Deficits in passive-avoidance learning following atropine in the developing rat, Psychopharmacology, 54 (1977) 139-143.
6. Buccafusco, J.J. and Jackson, W.J., Beneficial effects of nicotine administered prior to a delayed-matching-to-sample task in young and aged monkeys, Neurobiol. Aging, 12 (1991) 233-238.
7. Bucherelli, C., Tassoni, G. and Bures, J., Time-dependent disruption of passive avoidance acquisition by post-training intra-amygdala injection of tetrodotoxin in rats, Neurosci Lett., 140 (1992) 231-234.
8. Campbell, B.A. and Spear, N.E., Ontogeny of memory, Psychol. Rev., 79 (1972) 215-236.
9. Crow, T.J. and Grove-White, I.G., An analysis of the learning deficit following hyoscine administration to man, Br. J. Pharmacol., 49 (1973) 322-327.
10. Cumin, R. Bandle, E.F., Gamzu, E. and Haefely, W.E., Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents, Psychopharmacology, 78 (1982) 104-111.
11. Davies, P. and Maloney, A.J.F., Selective loss of cholinergic neurons in Alzheimer's disease, Lancet, 2 (1976) 1403.
12. Dawson, G.R., Heyes, C.M. and Iversen, S.D., Pharmacological mechanisms and animal models of cognition, Behav. Pharmacol., 3 (1992) 285-297.
13. Dobbing, J., Effect of experimental undernutrition on development of the nervous system. In N.S. Scrimshaw and J.E. Gordon (Eds.), Malnutrition, Learning and Behavior, Boston, M.I.T., 1968.
14. Drachman, D., Memory and cognitive function in man: does the cholinergic system have a specific role?, Neurology, 27 (1977) 783-790.
15. Dumery, V., Derer, P. and Blozovski, D., Enhancement of passive-avoidance learning through small doses of intra-amygdaloid physostigmine in the young rat. Its relation to the development of acetylcholinesterase, Dev. Psychobiol., 21 (1988) 553-565.
16. Feigley, D.A., Effects of scopolamine on activity and passive avoidance learning in rats of different ages, J. Comp. Physiol. Psychol., 87 (1974) 26-36.
17. Fibiger, H.C., Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence, Trends Neurosci., 14 (1991) 220-223.
18. Fischer, W., Nilsson, O.G. and Björklund, A., In vivo acetylcholine release as measured by microdialysis is unaltered in the hippocampus of cognitively-impaired aged rats with degenerative changes in the basal forebrain, Brain Res., 556 (1991) 44-52.
19. Flood, J.F., Landry, D.W. and Jarvik, M.E., Cholinergic receptor interactions and their effects on long-term memory processing, Brain Res., 215 (1981) 177-185.
20. Flood, J.F., Morley, J.E. and La Reginna, M., Age-related changes in the pharmacological improvement of retention in senescence accelerated mouse (SAM), Neurobiol. Aging, 14 (1993) 159-166.
21. Gaykema, R.P.A., Nyakas, C., Horvath, E., Hersh, L.B., Majtenyi, C. and Luiten, P.G.M., Cholinergic fiber aberrations in nucleus basalis lesioned rat and Alzheimer's disease, Neurobiol. Aging, 13 (1992) 441-448.
22. Green, R.J. and Stanton, M.E., Differential ontogeny of working memory and reference memory in the rat, Behav. Neurosci., 103 (1989) 98-105.
23. Grilly, D.M., Aging changes the effects of cocaine on vigilance task performance of rats, J. Gerontol., 47 (1992) 171-176.
24. Haroutunian, V., Barnes, E. and Davis, K.L., Cholinergic modulation of memory in rats, Psychopharmacology, 87 (1985) 266-271.
25. Heckers, S. and Mesulam, M.-M., Two types of cholinergic projections to the rat amygdala, Neuroscience, 60 (1994) 383-397.
26. Irwin, S., Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse, Psychopharmacology, 13 (1968) 222-257.
27. Itoh, J., Nabeshima, T. and Kameyama, T., Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock, Psychopharmacology, 101 (1990) 27-33.
28. Jarvick, M.E. and Essman, W.B., A simple one-trial learning situation for mice, Psychol. Rep., 6 (1960) 290-294.
29. Jones, G.M., Sahakiam, B.J., Levy, R., Wartburton, D.M. and Gray, J., Effect of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease, Psychopharmacology, 108 (1992) 485-494.
30. Levin, E.D., Nicotinic systems and cognitive function, Psychopharmacology 108 (1992) 417-431.
31. Levy, R., Cholinergic treatment of Alzheimer's disease. The clinical diagnosis of Alzheimer's disease. In A. Burns and R. Levy (Eds.), Dementia, Chapman and Hall, London, 1994, pp. 511-518.
32. Lindner, M.D. and Schallert, T., Aging and atropine effects on spatial navigation in the Morris water task, Behav. Neurosci., 102 (1988) 621-634.
33. Mallet, P.E., Beninger, R.J., Flesher, S.N., Jhamandas, K. and Boegman, R.J., Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory, Brain Res. Bull., 36 (1994) 51-56.
34. McGaugh, J.L. and Introini-Collision, I.B., Novel experience prior to training attenuates the amnestic effects of posttraining ECS, Behav. Neurosci., 101 (1987) 296-299.
35. Newhouse, P.A., Sunderland, T., Tariot, P.N., Blumhardt, C.L., Weingarten, H., Mellow, A. and Murphy, D.L., Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology, 95 (1988) 171-175.
36. Ohnishi, A., Mihara, M., Kamakura, H., Tomono, Y., Hasegawa, J., Yamazaki, K., Morishita, N. and Tanaka, T., Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects, J. Clin. Pharmacol., 33 (1993) 1086-1091.
37. Olton, D.S. and Wenk, G.L., Dementia: Animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In H.Y. Meltzer (Ed)., Psychopharmacology: The Third Generation of Progress, Raven, New York, 1987, pp. 941-953.
38. Palmer, A.M. and Gershon, S., Is the neuronal basis of Alzheimer's disease cholinergic or glutaminergic?, FASEB J., 4 (1990) 2745-2752.
39. Parada-Turska, J. and Turski, W.A., Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks, Neuropharmacology, 29 (1990) 1111-1116.
40. Perry, E.K., Tomlinson, B.E., Blessed, G., Bergman, K., Gibson, P.H. and Perry, R.H., Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia, Br. Med. J., 2 (1978) 1457-1459.
41. Perry, E.K., Cholinergic component of cognitive impairment in dementia. In A. Burns and R. Levy (Eds.), Dementia, Chapman and Hall, London, 1994, pp. 143-157.
42. Pontecorvo, M.J. and Clissold, D.B., Are better, more selective tests of cognitive performance by animals really necessary for Alzheimer's disease? Commentary on Dawson et al. 'Pharmacological mechanisms of animal cognition', Behav. Pharmacol., 3 (1992) 301-305.
43. Ridley, R.M., Bowes, P.M., Baker, H.F. and Crow, T.J., An involvement of acetylcholine in object discrimination learning and memory in the marmoset, Neuropsychologia, 22 (1984) 253-263.
44. Riekkinen, P. Jr., Sirviö, J., Aaltonen, M. and Riekkinen, P., Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning, Pharmacol., Biochem. Behav., 37 (1990) 405-410.
45. Riekkinen, P. Jr., Riekkinen, M., Lahtinen, H., Sirviö, J., Valjakka, A. and Riekkinen, P., Tetrahydroaminoacridine improves passive avoidance retention defects induced by aging and medial septal lesion but not by fimbria fornix lesion, Brain Res. Bull., 27 (1991) 587-594.
46. Rossor, M.N., Iversen, L.L., Reynolds, G.P., Mountjoy, C.Q. and Roth, M., Neurochemical characteristics of early and late onset types of Alzheimer's disease, Br. Med. J., 288 (1984) 961-964.
47. Saper, C.B., German, D.C. and White, C.L., Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer type: possible role in cell loss, Neurology, 35 (1985) 1089-1095.
48. Schulenburg, C.J., Riccio, D.C. and Stikes, E.R., Acquisition and retention of passive-avoidance as a function of age in rats, J. Comp. Physiol. Psychol., 74 (1971) 75-83.
49. Seiden, L.S. and Dykstra, L., Psychopharmacology: A Biochemical and Behavioral Approach, Van Nostrand Reinhold Company, 1977, pp. 283-431.
50. Sims, N.R., Bowen, D.M., Allen, S.J., Smith, C.C.T., Neary, D., Thomas, D.J. and Davison, A.N., Presynaptic cholinergic dysfunction in patients with dementia, J. Neurochem., 40 (1983) 503-509.
51. Smith, G., Animal models of Alzheimer's disease: Experimental cholinergic denervation, Brain Res. Rev., 13 (1988) 103-118.
52. Smith, R.D., Grzelak, M.E. and Coffin, V.L., Methylatropine blocks the central effects of cholinergic antagonists, Behav. Pharmacol., 5 (1994) 167-175.
53. Spear, L.P. and Brake, S.C., Periadolescence: age-dependent behavior and psychopharmacological responsivity in rats, Dev. Psychobiol., 16 (1983) 83-109.
54. Symons, J.P., Davis, R.E. and Marriott, J.G., Water-maze learning and effects of cholinerigic drugs in mouse strains with high and low hippocampal pyramidal cell counts, Life Sci., 42 (1988) 375-383.
55. Venault, P., Chapouthier, G., Prado de Carvalho, L., Simiand, J., Morre, M., Dodd, R.H. and Rossier, J., Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks, Nature, 321 (1986) 864-866.
56. Verloes, R., Scotto, A.-M., Gobert, J. and Wülfert, E., Effects of nootropic drugs in a scopolamine-induced amnesia model in mice, Psychopharmacology, 95 (1988) 226-230.
57. Whitehouse, P.J., Price, D.L., Struble, R.G., Clarke, A.W., Coyle, J.T. and DeLong, M.R., Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science, 215 (1983) 1237-1239.
58. Woods, J.H., Katz, J.L. and Winger, G., Benzodiazepines: use, abuse and consequence, Pharmacol. Rev., 44 (1992) 151-347.